Imaging Recommendations for Diagnosis, Staging, and Management of Esophageal Cancer

Nivedita Chakrabarty; Abhishek Mahajan; Prachi Patil; Manoranjan Chowhan; Naveen Munmmudi; Devayani Niyogi; Deepak Dabkara; Suryaveer Singh; Ajaykumar Singh; Sanjana Devarmani; Varun Singh Dhull; Kumar Prabhash

doi:10.1055/s-0042-1760324

Indian Journal of Medical and Paediatric Oncology, Table of Contents

CC BY 4.0 · Indian J Med Paediatr Oncol 2023; 44(02): 229-240
DOI: 10.1055/s-0042-1760324

Review Article

Imaging Recommendations for Diagnosis, Staging, and Management of Esophageal Cancer

Nivedita Chakrabarty

¹Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Abhishek Mahajan

²Department of Radiodiagnosis, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom

,

Prachi Patil

³Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Manoranjan Chowhan

⁴Department of Nuclear Medicine and PET/CT, Aditya Birla Memorial Hospital, Pune, Maharashtra, India

,

Naveen Munmmudi

⁵Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Devayani Niyogi

⁶Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Deepak Dabkara

⁷Department of Oncology, CHL Hospitals, Indore, Madhya Pradesh, India

,

Suryaveer Singh

¹Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Ajaykumar Singh

⁸Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Sanjana Devarmani

¹Department of Radiodiagnosis, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

,

Varun Singh Dhull

⁴Department of Nuclear Medicine and PET/CT, Aditya Birla Memorial Hospital, Pune, Maharashtra, India

,

Kumar Prabhash

⁸Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Tata Memorial Hospital, Mumbai, Maharashtra, India

› Author Affiliations

Abstract

Early staging and treatment initiation affect prognosis of patients with esophageal and esophagogastric junction cancer; hence, it is imperative to have knowledge of proper choice of imaging modality for staging of these patients, to effectively convey relevant imaging findings to the treating physician/surgeon. It is also essential to be aware of pertinent imaging findings that need to be conveyed to the treating physician/surgeon at staging, and after treatment, including post-therapy complications (if any), so as to provide timely management to such patients. In this article, we have provided imaging guidelines for diagnosis, staging, post-therapy response evaluation, follow-up, and assessment of post-therapy complications of esophageal and esophagogastric junction cancer in a systematic manner. Besides, risk factors and clinical workup have also been elucidated. We have also attached comprehensive staging and post-therapy contrast-enhanced computed tomography and fluorodeoxyglucose-positron emission tomography/computed tomography-based synoptic reporting formats “ECI-RADS” and “pECI-RADS,” respectively, for esophageal and esophagogastric junction cancer in the supplement, for effective communication of imaging findings between a radiologist and the treating physician/surgeon.

Keywords

esophageal cancer - imaging guidelines - staging - post-therapy - synoptic reporting formats

Full Text

References

References
1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
2 Jayaprakasam VS, Yeh R, Ku GY. et al. Role of imaging in esophageal cancer management in 2020: update for radiologists. AJR Am J Roentgenol 2020; 215 (05) 1072-1084
3 Kim TJ, Kim HY, Lee KW, Kim MS. Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 2009; 29 (02) 403-421
4 Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg 2017; 6 (02) 119-130
5 Daly JM, Fry WA, Little AG. et al. Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000; 190 (05) 562-572 , discussion 572–573
6 Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J. Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 2016; 27 (09) 1664-1674
7 Lee DJ, Harris A, Gillette A, Munoz L, Kashima H. Carcinoma of the cervical esophagus: diagnosis, management, and results. South Med J 1984; 77 (11) 1365-1367
8 Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á. Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21 (26) 7933-7943
9 Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg 2018; 41 (03) 210-215
10 Watanabe M. Risk factors and molecular mechanisms of esophageal cancer: differences between the histologic subtypes. J Cancer Metastasis Treat 2015; 1: 1-7
11 Choksi D, Kolhe KM, Ingle M. et al. Esophageal carcinoma: an epidemiological analysis and study of the time trends over the last 20 years from a single center in India. J Family Med Prim Care 2020; 9 (03) 1695-1699
12 Sekar A, Rajendra A, Noronha V. et al. The epidemiological trend of esophageal cancer in Mumbai, India over the past two decades. Journal of Clinical Oncology 2021; 39 (15_suppl) e16095-e16095
13 Accessed December 10, 2022, at: https://gco.iarc.fr/today/data/factsheets/populations/356-india-fact-sheets.pdf
14 Accessed December 10, 2022, at: https://gco.iarc.fr/today/data/factsheets/cancers/6-Oesophagus-fact-sheet.pdf
15 Accessed December 10, 2022, at: https://www.msdmanuals.com/en-in/professional/gastrointestinal-disorders/tumors-of-the-gastrointestinal-tract/esophageal-cancer
16 Accessed December 10, 2022, at: https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
17 Lordick F, Mariette C, Haustermans K, Obermannová R, Arnold D. ESMO Guidelines Committee. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27 (suppl 5): v50-v57
18 Accessed December 10, 2022, at: https://tmc.gov.in/ncg/docs/PDF/DraftGuidelines/ThoacicGuidelinesAndResearch/NCG_Esophageal_Cancer_Guidelines.pdf
19 Accessed December 10, 2022, at: https://iria.org.in/oncologic-imaging-protocols-and-reporting-checklist/
20 Accessed December 10, 2022, at: https://acsearch.acr.org/docs/69471/narrative/
21 Elsherif SB, Andreou S, Virarkar M. et al. Role of precision imaging in esophageal cancer. J Thorac Dis 2020; 12 (09) 5159-5176
22 Iyer R, Dubrow R. Imaging of esophageal cancer. Cancer Imaging 2004; 4 (02) 125-132
23 Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349 (23) 2241-2252
24 Shah MA, Kennedy EB, Catenacci DV. et al. Treatment of locally advanced esophageal carcinoma: ASCO guideline. J Clin Oncol 2020; 38 (23) 2677-2694
25 Convie L, Thompson RJ, Kennedy R, Clements WD, Carey PD, Kennedy JA. The current role of staging laparoscopy in oesophagogastric cancer. Ann R Coll Surg Engl 2015; 97 (02) 146-150
26 Dhakras P, Uboha N, Horner V, Reinig E, Matkowskyj KA. Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma. Transl Gastroenterol Hepatol 2020; 5: 55
27 DaVee T, Ajani JA, Lee JH. Is endoscopic ultrasound examination necessary in the management of esophageal cancer?. World J Gastroenterol 2017; 23 (05) 751-762
28 Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol 2016; 13 (12) 720-730
29 Bang JY, Ramesh J, Hasan M. et al. Endoscopic ultrasonography is not required for staging malignant esophageal strictures that preclude the passage of a diagnostic gastroscope. Dig Endosc 2016; 28 (06) 650-656
30 Erasmus JJ, Munden RF. The role of integrated computed tomography positron-emission tomography in esophageal cancer: staging and assessment of therapeutic response. Semin Radiat Oncol 2007; 17 (01) 29-37 s.
31 Mamede M, Abreu-E-Lima P, Oliva MR, Nosé V, Mamon H, Gerbaudo VH. FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results. Am J Clin Oncol 2007; 30 (04) 377-388
32 Rustgi AK, El-Serag HB. Esophageal Carcinoma. New England Journal of Medicine 2014; 371 (26) 2499-2509
33 Chen SH, Chan SC, Chao YK. et al. Detection of synchronous cancer by flurodeoxy glucose positron emission tomography/CT during primary staging work up for esophageal squamous cell carcinoma in Taiwan. PLoS One 2013; 8 (11) e82812
34 Metzger JC, Wollschläger D, Miederer M. et al. Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosis. Strahlenther Onkol 2017; 193 (10) 791-799
35 Zhong X, Yu J, Zhang B. et al. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 73 (01) 136-141
36 Lee G, Hoseok I, Seong-Jung K. et al. Clinical implication of PET-CT, MR in preoperative esophageal carcinoma staging compared with PETCT, EUS and CT. JNM 2014; 55 (08) 1242-1247
37 Taniyama Y, Murakami K, Yoshida N. et al. Evaluating the effect of Neoadjuvant chemotherapy for esophageal cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study. BMC Cancer 2021; 21 (01) 1008
38 Lee S, Choi Y, Park G. et al. ¹⁸F-FDG PET/CT parameters for predicting prognosis in esophageal cancer patients treated with concurrent chemoradiotherapy. Technol Cancer Res Treat 2021 Jan-Dec;20–15330338211024655
39 Hodi FS, Ballinger M, Lyons B. et al. Immune-modified response evaluation criteria in solid tumors (imRECIST): refining guidelines to assess the clinical benefit of cancer immunotherapy. J Clin Oncol 2018; 36 (09) 850-858
40 Chakrabarty N, Mahajan A, Baheti AD. et al. A radiologist's perspective on treatment-related pseudo progression: clues and hues. Indian J Med Paediatr Oncol 2022; 43 (01) 52-59
41 Sudo K, Xiao L, Wadhwa R. et al. Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 2014; 32 (30) 3400-3405
42 Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24 (35) 3965-3973 cited 2022Mar2 [Internet]
43 Al-Batran SE, Homann N, Pauligk C. et al; FLOT4-AIO Investigators. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 2019;393(10184):1948–1957 cited 2022Feb11 [Internet]
44 Allum WH, Bonavina L, Cassivi SD. et al. Surgical treatments for esophageal cancers. Ann N Y Acad Sci 2014; 1325 (01) 242-268 cited 2022Mar2 [Internet]
45 Cancer E. Statistics | Cancer.Net [Internet]. [cited 2022 Mar 2]. Accessed December 10, 2022, at: Available from: https://www.cancer.net/cancer-types/esophageal-cancer/statistics
46 Zeng C, Zhai T, Chen J. et al. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy. Radiat Oncol 2021; 16 (01) 8
47 Mantziari S, Pomoni A, Prior JO. et al. ¹⁸F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer. BMC Med Imaging 2020; 20 (01) 7
48 Park J-H, Kim KY, Song H-Y. et al. Radiation-induced esophageal strictures treated with fluoroscopic balloon dilation: clinical outcomes and factors influencing recurrence in 62 patients. Acta Radiol 2018; 59 (03) 313-321
49 Chakrabarty N, Mahajan A. Esophageal cancer imaging - reporting and data system (ECI-RADS) and post-therapy ECI-RADS (pECI-RADS): Comprehensive synoptic reporting formats for esophageal cancer imaging: A narrative review. Cancer Research, Statistics, and Treatment 2022;5(03)